Modern approaches to the diagnosis and surgical treatment of rectal cancer (Review of clinical recommendations)
DOI:
https://doi.org/10.34287/MMT.1(40).2019.12Abstract
Colorectal cancer (CRC) ranks third in the structure of cancer morbidity and is the fourth most frequent cause of death from malignant neoplasms. The World Health Organization predicts an increase in the number of newly diagnosed cases of CRC by 77% and deaths from this disease by 80% by 2030. In this review, modern standards for the diagnosis and treatment of colorectal cancer (CRC) are analyzed. Based on the literature analysis data, the surgical operation continues to be the main method of treatment. At the moment, there are different views on the volume of lymphadenectomy in the CRC and the choice of combined treatment. The question of pelvic lymphadenectomy remains the most controversial.
References
Stewart B., Wild C. P. World Cancer Report 2014. International Agency for Research on Cancer (IARC). Lyon, France.
Glynne-Jones R. et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 2017, vol. 28, iss. suppl 4, pp iv22–iv40. https://doi.org/10.1093/annonc/mdx224.
Bulletin of National cancer registry of Ukraine, 2018, № 19, pp. 19–21.
Beaugerie L. et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology, 2013, vol. 145, № 1, pp. 166–175. DOI:10.1053/j.gastro.2013.03.044.
Johnson C. M. et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control, 2013, vol. 24, № 1, pp. 1207–1222. DOI: 10.1007/s10552-013-0201-5.
Lutgens M. W. et al. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis., 2013, vol. 19, № 4, pp. 789–799. DOI: 10.1097/MIB.0b013e31828029c0.
Huxley R. R. et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int. J. Cancer, 2009, vol. 125, № 1, pp. 171–180. DOI: 10.1002/ijc.24343.
Kirkegaard H. et al. Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ, 2010, vol. 341, c5504. DOI: doi.org/10.1136/bmj.c5504.
Aleksandrova K. et al. Combined impact of healthylifestyle factors on colorectal cancer: a large European cohort study. BMC Med., 2014, 12, 168. DOI: doi.org/10.1186/s12916-014-0168-4.
Murphy N. et al. Dietary fibre intake and risks of cancersof the colon and rectum in the European prospective investigation into cancer and nutrition (EPIC). PLoS One, 2012, vol. 7, № 1, e39361. DOI: 10.1371/journal. pone.0039361.
Orlich M. J. et al. Vegetarian dietary patterns and the risk of colorectal cancers. JAMA Intern Med., 2015, vol. 175, № 5, pp. 767–776. DOI: 10.1001/jamainternmed.2015.59.
Hennink S. D. et al. Randomized comparison of surveillance intervals in familial colorectal cancer. J. Clin. Oncol., 2015, vol. 33 (35), pp. 4188–4193. DOI: 10.1200/JCO.2015.62.2035.
Rex D. K. et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am. J. Gastroenterol., 2017, vol. 112, № 7, pp. 1016–1030. DOI: 10.1038/ajg.2017.174.
Choi D. J. et al. Preoperative chest computerized tomography in patients with locally advanced mid or lower rectal cancer: its role in staging and impact on treatment strategy. J Surg. Oncol., 2010, vol. 102, pp. 588–592. https://doi.org/10.1002/jso.21651.
Grossmann I., Avenarius J. K., Mastboom W. J., Klaase J. M. Preoperative staging with chest CT in patients withc olorectal carcinoma: notas a routine procedure. Ann. Surg. Oncol., 2010, vol. 17, № 8, pp. 2045–2050. DOI: 10.1245/s10434-010-0962-y.
Qiu M., et al. Pattern of distant metastases in colorectal cancer: a SEER based study. Oncotarget, 2015, vol. 36, № 6, pp. 38658–38666. DOI: 10.18632/oncotarget.6130.
Bartram C., Brown G. Endorectal ultrasound and magnetic resonance imaging in rectal cancer staging. Gastroenterol. Clin. North Am., 2002, vol. 31, № 3, pp. 827–839.
Van Cutsem E., et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol., 2016, vol. 27, № 8, pp. 1386–1422. DOI: 10.1093/annonc/mdw235.
Papamichael D. et al. Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann. Oncol., 2015, vol. 26, № 3, pp. 463–476. DOI: 10.1093/annonc/mdu253.
de Rosa N. et al. DNA mismatch repair deficiency in rectal cancer: benchmarking its impact on prognosis, neoadjuvant response prediction, and clinical cancer genetics. J. Clin. Oncol., 2016, vol. 34 (25), pp. 3039–3046. DOI: 10.1200/JCO.2016.66.6826
Cooper H. S. et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology, 1995, vol. 108, № 6, pp. 1657–1665.
Yoshii S. et al. Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. Clin. Gastroenterol. Hepatol., 2014, vol. 12, № 2, pp. 292–302. DOI: 10.1016/j.cgh.2013.08.008.
Volk E. E. et al. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology, 1995, vol. 109, № 6, pp. 1801–1807.
Ueno H. et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology, 2004, vol. 127, № 2, pp. 385–394.
Seitz U. et al. Is endoscopic polypectomy an adequate the rapy for malignant colorectal polyps? Presentation of 114 patients and review of the literature. Dis. Colon Rectum, 2004, vol. 47, № 11, pp. 1789–1797.
Stitzenberg K. B. et al. Practice patterns and long-term survival for early-stage rectal cancer. J. Clin. Oncol., 2013, vol. 31 (34), pp. 4276–4282. DOI: 10.1200/JCO.2013.49.1860.
Guillem J. G., Cohen A. M. Current surgery. issues in colorectal cancer. Semin. Oncol., 1999, vol. 26, № 5, pp. 505–513.
Lindsetmo R. O., Joh Y. G., Delaney C. P. Surgical treatment for rectal cancer: An international perspective on what the medical gastroenterologist needs to know. World J. Gastroenterol, 2008, vol. 14 (21), № 7, pp. 3281–3289. DOI: 10.3748/wjg.14.3281.
Heald R. J., Husband E. M., Ryall R. D. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br. J. Surg., 1982, vol. 69, № 10, pp. 613–616.
MacFarlane J. K., Ryall R. D., Heald R. J. Mesorectal excision for rectal cancer. Lancet, 1993, 341 (8843), pp. 457–460.
Enker W. E. et al. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J. Am. Coll Surg., 1995, vol. 181, № 4, pp. 335–346.
Lowry A. C., et al. Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington DC, May 1, 1999. Dis Colon Rectum, 2001, vol. 44, pp. 915–919.
Schlag P. M. et al. Surgical sphincter preservation in rectal cancer. Oncologist, 1996, № 1, pp. 288–292. http://theoncologist.alphamedpress. org/content/1/5/288.full.
Watanabe T. et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Treatment of Colorectal Cancer. Int. J. Clin. Oncol., 2018, vol. 23, № 1, pp. 1–34. DOI: 10.1007/s10147-017-1101-6.
Compton C. C., Greene F. L. The staging of colorectal cancer: 204 and beyond. Cancer J. Clin., 2004, vol. 54, № 6, pp. 295–308.
Holm T. et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor forrectal cancer. Br. J. Surg., 2007, vol. 94, № 2, pp. 232–238. DOI: 10.1002/bjs.5489.
Stelzner S., Koehler C., Stelzer J., Sims A., Witzigmann H. Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer – a systematic overview. Int. J. Colorectal Dis., 2011, vol. 26, № 10, pp. 1227–1240. DOI: 10.1007/s00384-011-1235-3.
Battersby N. J. et al. Prospective validation of a low rectalcancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann. Surg., 2016, vol. 263, № 4, pp. 751–760. DOI: 10.1097/ SLA.0000000000001193.
West N. P. et al. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br. J. Surg., 2010, vol. 97, № 4, pp. 588–599. DOI: 10.1002/bjs.6916.
Jayne D. G. et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year resultsofthe UK MRC CLASICC Trial Group. J. Clin. Oncol., 2007, vol. 25 (21), pp. 3061–3068. DOI: 10.1200/JCO.2006.09.7758.
Jeong S. Y. et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an openlabel, non-inferiority, randomised controlled trial. Lancet Oncol., 2014, vol. 15, № 7, pp. 767–774. DOI: 10.1016/S1470-2045(14)70205-0.
Araujo S. E. et al. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev. Hosp. Clin. Fac. Med. Sao Paulo, 2003, vol. 58, № 3, pp. 133–140.
Desch C. E. et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology Practice Guideline. J. Clin. Oncol., 2005, vol. 23 (20), pp. 8512–8519. DOI: 10.1200/JCO.2005.04.0063.
Kahi C. J. et al. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am. J. Gastroenterology, 2016, vol. 111, № 3, pp. 337–346. DOI: 10.1038/ajg.2016.22.
